top of page
Search

Asha Therapeutics presents at 5th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference

  • Jun 21, 2022
  • 1 min read

Updated: May 21

Sam Shrivastava (Asha CEO) and Dr. Bradlee Heckmann (Asha CSO) present updates on neuro-oncology assets and ASHA-044


ree


 
 
 

Comments

bottom of page